ICG Use in Angiography for Nasoseptal Flap Harvest

Completed · Not applicable

Conditions studied: Skull Base Neoplasms

In brief

This is a feasibility study in which indocyanine green (ICG) will be administered during routine expanded endonasal approach (EEA) for cranial base pathologies in which a nasoseptal flap harvest will be necessary. The research entails administering ICG, which is already widely used during open neurosurgical procedures, to identify the blood supply at two distinct stages of endonasal cranial base surgery: during nasoseptal flap harvest and after final positioning of the nasoseptal flap to ensure its viability before ending the case.

Key facts

Study ID

NCT02117310

Run by

Ohio State University

People needed

5

Starts

2015-03-01

Expected to finish

2015-11-01

Last updated by the study team

2017-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 and above
• Patients undergoing an EEA for cranial base pathology that may require nasoseptal flap harvest

You may not qualify if…

• History of sulfa, iodide, or penicillin allergy
• Pregnant or breast feeding
• Preoperative lack of indication for nasoseptal flap harvest
• Previous anaphylactic reaction to ICG

Where it is running

• The Ohio State University — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.